NCT00223249 Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence Status COMPLETED Phase PHASE4
NCT00223210 An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence Status COMPLETED Phase PHASE4
NCT00223197 Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse Status COMPLETED Phase PHASE4
NCT00221975 Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling Status COMPLETED Phase PHASE3
NCT00221481 An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder Status WITHDRAWN Phase PHASE4
NCT00221429 Lithium Versus Divalproex for Treating Pediatric Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00221416 An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00221403 Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders Status COMPLETED Phase PHASE3
NCT00217217 Low Field Magnetic Stimulation Treatment for Bipolar Depression Status TERMINATED Phase PHASE3
NCT00217165 Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study Status COMPLETED Phase PHASE2
NCT00216723 Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder Status COMPLETED Phase N/A
NCT00216554 The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania Status COMPLETED Phase PHASE4
NCT00214877 Methylene Blue for Cognitive Dysfunction in Bipolar Disorder Status COMPLETED Phase PHASE3
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Status COMPLETED Phase PHASE4
NCT00206544 Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? Status COMPLETED Phase PHASE2